What Are the Challenges in Genomic and Proteomic Analyses?
Despite their potential, these analyses face several challenges:
Data Complexity: The vast amount of data generated requires sophisticated computational tools for analysis and interpretation. Heterogeneity: Cancer is highly heterogeneous, both between patients (inter-tumor) and within a single tumor (intra-tumor), complicating analysis. Validation: Findings from genomic and proteomic studies need rigorous validation in clinical settings. Cost: High costs associated with advanced technologies can be a barrier to widespread implementation.
